World Solve

Chronic malnutrition in early childhood can cause lasting physical and cognitive effects that are difficult to reverse later in life. Preventing this before it happens remains far more effective, and far less solved, than treating it afterward.

This parasitic disease continues to cause preventable blindness in parts of Africa and Latin America, largely due to limited access to consistent treatment. Expanding affordable access remains the main barrier rather than lack of an effective treatment.

Vaccines are safe and effective for the vast majority of people, but a small number experience severe reactions for reasons not yet fully understood. Better prediction of who's at risk could make vaccination even safer.

Patients who've had one dangerous blood clot are at ongoing risk of another, and current prevention relies mainly on long-term blood thinners that carry their own risks. A more targeted, lower-risk prevention method remains needed.

Research shows a strong link between childhood trauma and adult physical illness, but effective, scalable prevention and early intervention remain limited. Closing this gap could improve both mental and physical health outcomes across entire populations.

Extended time in a hospital bed, especially in intensive care, can cause significant muscle loss that affects recovery and long-term function. Better prevention methods during hospitalization remain underdeveloped.

A subset of patients with chronic hives don't respond well to typical antihistamine treatment, leaving them with persistent, disruptive symptoms and few further options. More effective alternatives remain limited.

Many people who experience one episode of depression go on to experience another, and current treatments don't reliably prevent this recurrence. Better long-term prevention strategies remain an important gap in mental health care.

Osteoarthritis treatment currently focuses on managing pain and preserving remaining function rather than restoring lost cartilage. A regenerative treatment could transform care for one of the most common causes of chronic pain in older adults.

This parasitic disease affects millions in tropical and subtropical regions, but effective treatment remains expensive, difficult to access, or logistically challenging for many affected communities. Closing this access gap remains unresolved.

Diabetic retinopathy remains a leading cause of blindness among working-age adults, and while treatment can slow progression, prevention before damage begins remains incomplete. Earlier, more effective prevention could protect vision for millions of diabetics.

Persistent dizziness and balance problems can severely affect quality of life, yet treatment for many chronic cases remains limited and inconsistent. A more reliable, targeted treatment approach remains undeveloped.

Highly effective hepatitis C treatments exist, but cost and healthcare access still prevent many infected people worldwide from receiving them. Expanding affordable access remains the primary barrier rather than the science itself.

Many people with chronic insomnia end up relying on sleep medication for years, since non-drug treatments don't work consistently for everyone. A more effective, sustainable solution remains an open need.

Diabetes can lead to serious complications like blindness, kidney failure, or amputation, but predicting which patients are most at risk early enough to intervene remains imprecise. Better prediction could allow more targeted, effective prevention.

Effective vaccines exist for a small number of sexually transmitted infections, but many common ones still have no vaccine available at all. Expanding vaccine coverage here could significantly reduce global disease burden.

Glaucoma often causes irreversible vision loss before it's diagnosed, since early stages typically have no noticeable symptoms. Better early detection and prevention methods remain a pressing unmet need in eye care.

Effective treatments for hepatitis B exist, but cost and access remain out of reach for many of the hundreds of millions of people living with the infection globally, particularly in lower-income regions. Closing this access gap remains unresolved.

By the time visible symptoms of Parkinson's appear, significant neurological damage has usually already occurred, limiting how much treatment can help. Detecting the disease years earlier could open the door to more effective intervention.

Existing treatments for hair loss can slow the process for some people but rarely reverse it completely, and the underlying biology of hair follicle loss isn't fully understood. A true prevention or reversal method remains undiscovered.